Glycolaldehyde impairs neutrophil biochemical parameters by an oxidative and calcium-dependent mechanism-Protective role of antioxidants astaxanthin and vitamin C

Diabetes Research and Clinical Practice

Volumn 98, Issue 1, 2012, Pages 108-118

  Guerra, Beatriz Alves ^a   Bolin, Anaysa Paola ^a   Morandi, Ana Carolina ^a   Otton, Rosemari ^a  

^a UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

Author keywords

Antioxidant; Carbonylic stress; Free radical; Glycation; Leukocyte

Indexed keywords

ALDEHYDE; ASCORBIC ACID; ASTAXANTHIN; CALCIUM ION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLYCOLALDEHYDE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NEUTROPHIL; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PHAGOCYTOSIS;

ACETALDEHYDE; ANTIOXIDANTS; ASCORBIC ACID; CELL MEMBRANE; CELLS, CULTURED; FEMALE; HUMANS; MALE; NEUTROPHILS; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; XANTHOPHYLLS; YOUNG ADULT;

EID: 84867395254     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.07.004     Document Type: Article

References (62)

1. Glomb M.A., Monnier V.M. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 1995, 270:10017-10026.
2. Al-Enezi K.S., Alkhalaf M., Benov L.T. Glycolaldehyde induces growth inhibition and oxidative stress in human breast cancer cells. Free Radic Biol Med 2006, 40:1144-1151.
3. Pedchenko V.K., Chetyrkin S.V., Chuang P., Ham A.J., Saleem M.A., Mathieson P.W., et al. Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes 2005, 54:2952-2960.
4. Mera K., Nagai M., Brock J.W., Fujiwara Y., Murata T., Maruyama T., et al. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. J Immunol Methods 2008, 334:82-90.
5. Knott H.M., Brown B.E., Davies M.J., Dean R.T. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur J Biochem 2003, 270:3572-3582.
6. Higashida T., Kanno H., Nakano M., Funakoshi K., Yamamoto I. Expression of hypoxia-inducible angiogenic proteins (hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and E26 transformation-specific-1) and plaque hemorrhage in human carotid atherosclerosis. J Neurosurg 2008, 109:83-91.
7. Sakata T., Niwa Y., Goto H., Hirooka Y., Hayakawa T., Ohmiya N., et al. Asymptomatic inflammatory bowel disease with special reference to ulcerative colitis in apparently healthy persons. Am J Gastroenterol 2001, 96:735-739.
8. Anderson M.M., Hazen S.L., Hsu F.F., Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest 1997, 99:424-432.
9. Nagai R., Hayashi C.M., Xia L., Takeya M., Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem 2002, 277:48905-48912.
10. Anderson M.M., Heinecke J.W. Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. Diabetes 2003, 52:2137-2143.
11. Robertson P., Fridovich S.E., Misra H.P., Fridovich I. Cyanide catalyzes the oxidation of alpha-hydroxyaldehydes and related compounds: monitored as the reduction of dioxygen, cytochrome c, and nitroblue tetrazolium. Arch Biochem Biophys 1981, 207:282-289.
12. Thornalley P., Wolff S., Crabbe J., Stern A. The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochim Biophys Acta 1984, 797:276-287.
13. Sakurai T., Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett 1988, 236:406-410.
14. Zanotto-Filho A., Schroder R., Moreira J.C. Xanthine oxidase-dependent ROS production mediates vitamin A pro-oxidant effects in cultured Sertoli cells. Free Radic Res 2008, 42:593-601.
15. Borregaard N., Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89:3503-3521.
16. Lorenz R.T., Cysewski G.R. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol 2000, 18:160-167.
17. Hussein G., Sankawa U., Goto H., Matsumoto K., Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 2006, 69:443-449.
18. Ranga Rao A., Raghunath Reddy R.L., Baskaran V., Sarada R., Ravishankar G.A. Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model. J Agric Food Chem 2010, 58:8553-8559.
19. Otton R., Marin D.P., Bolin A.P., Santos Rde C., Polotow T.G., Sampaio S.C., et al. Astaxanthin ameliorates the redox imbalance in lymphocytes of experimental diabetic rats. Chem Biol Interact 2011, 186:306-315.
20. Bolin A.P., Macedo R.C., Marin D.P., Barros M.P., Otton R. Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes. Cell Biol Toxicol 2010.
21. Macedo R.C., Bolin A.P., Marin D.P., Otton R. Astaxanthin addition improves human neutrophils function: in vitro study. Eur J Nutr 2010, 49:447-457.
22. Otton R., Marin D.P., Bolin A.P., de Cassia Santos Macedo R., Campoio T.R., Fineto C., et al. Combined fish oil and astaxanthin supplementation modulates rat lymphocyte function. Eur J Nutr 2011, [epub ahead of print].
23. Mattei R., Polotow T.G., Vardaris C.V., Guerra B.A., Leite J.R., Otton R., et al. Astaxanthin limits fish oil-related oxidative insult in the anterior forebrain of Wistar rats: putative anxiolytic effects?. Pharmacol Biochem Behav 2011, 99:349-355.
24. Guerra B.A., Otton R. Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose. Int Immunopharmacol 2011, 11:2220-2226.
25. Levy R., Shriker O., Porath A., Riesenberg K., Schlaeffer F., Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions. J Infect Dis 1996, 173:1502-1505.
26. Sharma P., Raghavan S.A., Saini R., Dikshit M. Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide. J Leukoc Biol 2004, 75:1070-1078.
27. Krause R., Patruta S., Daxbock F., Fladerer P., Biegelmayer C., Wenisch C. Effect of vitamin C on neutrophil function after high-intensity exercise. Eur J Clin Invest 2001, 31:258-263.
28. Lorenzi R., Andrades M.E., Bortolin R.C., Nagai R., Dal-Pizzol F., Moreira J.C. Glycolaldehyde induces oxidative stress in the heart: a clue to diabetic cardiomyopathy?. Cardiovasc Toxicol 2010, 10:244-249.
29. Sampaio S.C., Sousa-e-Silva M.C., Borelli P., Curi R., Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J Leukoc Biol 2001, 70:551-558.
30. Dypbukt J.M., Bishop C., Brooks W.M., Thong B., Eriksson H., Kettle A.J. A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med 2005, 39:1468-1477.
31. Vinolo M.A., Hatanaka E., Lambertucci R.H., Newsholme P., Curi R. Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochem Funct 2009, 27:48-55.
32. Hatanaka E., Levada-Pires A.C., Pithon-Curi T.C., Curi R. Systematic study on ROS production induced by oleic, linoleic, and gamma-linolenic acids in human and rat neutrophils. Free Radic Biol Med 2006, 41:1124-1132.
33. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 1981, 46:211-226.
34. Brandt R., Keston A.S. Synthesis of diacetyldichlorofluorescin: a stable reagent for fluorometric analysis. Anal Biochem 1965, 11:6-9.
35. Crow J.P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997, 1:145-157.
36. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988, 141:2407-2412.
37. Otton R., da Silva D.O., Campoio T.R., Silveira L.R., de Souza M.O., Hatanaka E., et al. Non-esterified fatty acids and human lymphocyte death: a mechanism that involves calcium release and oxidative stress. J Endocrinol 2007, 195:133-143.
38. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
39. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
40. Ewing J.F., Janero D.R. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem 1995, 232:243-248.
41. Mannervik B. Glutathione peroxidase. Methods Enzymol 1985, 113:490-495.
42. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol 1985, 113:484-490.
43. Rahman I., Kode A., Biswas S.K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2006, 1:3159-3165.
44. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
45. 2-treated HL60 cells. Free Radic Biol Med 2011, 51:1399-1405.
46. Marin D.P., Bolin A.P., Macedo Rde C., Sampaio S.C., Otton R. ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int Immunopharmacol 2011, 11:103-109.
47. Jiang Q., Griffin D.A., Barofsky D.F., Hurst J.K. Intraphagosomal chlorination dynamics and yields determined using unique fluorescent bacterial mimics. Chem Res Toxicol 1997, 10:1080-1089.
48. Butkovskaya N.I., Pouvesle N., Kukui A., Bras G.L. Mechanism of the OH-initiated oxidation of glycolaldehyde over the temperature range 233-296K. J Phys Chem A 2006, 110:13492-13499.
49. Lorenzi R., Andrades M.E., Bortolin R.C., Nagai R., Dal-Pizzol F., Moreira J.C. Circulating glycolaldehyde induces oxidative damage in the kidney of rats. Diabetes Res Clin Pract 2010, 89:262-267.
50. Yang K., Feng C., Lip H., Bruce W.R., O'Brien P.J. Cytotoxic molecular mechanisms and cytoprotection by enzymic metabolism or autoxidation for glyceraldehyde, hydroxypyruvate and glycolaldehyde. Chem Biol Interact 2011, 191:315-321.
51. Sethi S., Dikshit M. Modulation of polymorphonuclear leukocytes function by nitric oxide. Thromb Res 2000, 100:223-247.
52. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
53. Sharma P., Raghavan S.A., Dikshit M. Role of ascorbate in the regulation of nitric oxide generation by polymorphonuclear leukocytes. Biochem Biophys Res Commun 2003, 309:12-17.
54. Ukeda H., Hasegawa Y., Harada Y., Sawamura M. Effect of carnosine and related compounds on the inactivation of human Cu, Zn-superoxide dismutase by modification of fructose and glycolaldehyde. Biosci Biotechnol Biochem 2002, 66:36-43.
55. Washko P.W., Wang Y., Levine M. Ascorbic acid recycling in human neutrophils. J Biol Chem 1993, 268:15531-15535.
56. Cassatella M. The neutrophil-an emerging regulator of inflammatory and immune response, illustrated ed. Basel: Karger Publishers; 2003.
57. Janssen-Heininger Y.M., Poynter M.E., Baeuerle P.A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 2000, 28:1317-1327.
58. Palombella V.J., Rando O.J., Goldberg A.L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994, 78:773-785.
59. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071.
60. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
61. Choi S.K., Park Y.S., Choi D.K., Chang H.I. Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J Microbiol Biotechnol 2008, 18:1990-1996.
62. Kim Y.H., Koh H.K., Kim D.S. Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-kappaB-mediated signals in activated microglia. Int Immunopharmacol 2010, 10:1560-1572.